Dyne Therapeutics · 20 hours ago
VP, DMD Commercial Asset Lead
Waltham, MA
Full-time
Onsite
Director/Executive
$272K/yr - $340K/yr
20+ years expDyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The VP, DMD Commercial Asset Lead is responsible for maximizing the value of Dyne’s DMD commercial assets through strategic commercialization efforts and cross-functional collaboration to ensure successful product launches globally.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Define global asset commercialization strategy and plan to achieve milestones and timelines for successful launches
As a key member of the Program Team and Head of DMD Commercial Sub Team, they ensure that all key pillars for successful commercialization for the assets are secured – starting with differentiation in endpoints to achieve a competitive product profile/label, regulatory strategy, filing strategy, with value & access to secure the value proposition for the assets and achieve reimbursement in US and at the right time globally, partner with supply, medical, marketing, digital and the data team to prepare successful launch strategy and execution for all key markets starting with US
Provide input and expertise to a robust and well-understood program strategy with the key objective of gaining the approvals of potentially life-changing medicines for patients around the world to generate value for patients and shareholders and maximize topline growth
Structure and facilitate critical cross-functional decisions on commercialization aspects of the asset within Program Teams and senior leadership teams, bringing all relevant perspectives to bear while driving to efficient decisions in a fast-paced environment
Working with cross-functional launch team in key markets, starting with the US team, and Strategic Commercialization Partners to secure reimbursement and successful launches, by propelling successful launch execution from one country to the other
In close collaboration with the Program Lead and Head of Commercialization, consider and advocate for the needs of the commercial asset in the context of Dyne’s corporate strategy and priorities
Drive preparation and presentation of materials for Board of Directors on asset commercialization topics
Maintain clear, open, and proactive communication with the senior leadership team and other stakeholders regarding commercialization strategy, status, priorities, risks and needs, and facilitate appropriate decision-making
Keep abreast of competitor landscape and development in the fields of muscle diseases and oligonucleotide drug discovery and development
Build visible, constructive, and credible presence within the DMD community including with KOLs, the holistic teams engaged in patient care and patient community
Participate in business development activities, as needed, including opportunity evaluations and due diligence
Provide a motivating leadership example within Dyne more broadly during periods of rapid growth
Foster a culture of collaboration, innovation, discovery, and cutting-edge research
Focused on scientific excellence, open communication, and continuous improvement
Role model Dyne’s core values
Qualification
Required
Bachelor's degree in a relevant scientific, medical, or business discipline required
Minimum of 20 years of experience in the biopharmaceutical industry
15+ years of commercialization and cross-functional leadership experience within the biopharmaceutical industry, including substantial involvement in clinical development strategy, regulatory interactions, filing preparation, and lifecycle planning
Extensive experience leading global product launches, including development of launch strategy, execution, and cross-functional commercialization planning
Proven track record of delivering on business objectives in fast-paced, high-stakes environments
Steering assets from late stage development through approval and launch
Influencing global and U.S. market access, value evidence generation, and reimbursement readiness
Experience collaborating closely with clinical development, medical affairs, supply chain, marketing, digital/data teams, and affiliate launch organizations
Expertise in global asset commercialization, including competitive positioning, launch sequencing, market shaping, and lifecycle strategy
Ability to synthesize scientific, clinical, regulatory, and market data to guide asset and commercialization strategy
Fluency with digital launch tools, analytics platforms, and data driven decision-making
Entrepreneurial, self-driven leader capable of articulating a compelling vision and mobilizing high performing cross functional teams
Strong people leadership skills with the ability to coach, influence, and inspire diverse functional experts
Exceptional communication skills, including clear and effective engagement with executive leadership, affiliates, external partners, Boards of Directors, and patient communities
Proven ability to build strong, credible relationships with KOLs, advocacy groups, payers, regulators, and other key stakeholders
Comfortable leading through ambiguity, adapting to evolving priorities, and driving alignment in a dynamic environment
High integrity, strong patient centric mindset, and alignment with Dyne's core values
Strong sense of urgency with the ability to pace and prioritize workstreams in competitive and fast-moving environments
Transparent, inclusive communicator with a collaborative leadership style
Preferred
advanced degree (MD, PhD, PharmD, MBA, or Master's in Life Sciences) strongly preferred
Rare disease launch experience strongly preferred
neuromuscular disease experience highly advantageous
Company
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
51-200 employees
H1B Sponsorship
Dyne Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (7)
2023 (1)
2022 (3)
2021 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.67BKey Investors
Hercules CapitalAtlas Venture
2025-12-09Post Ipo Equity· $402.5M
2025-06-30Post Ipo Equity· $230M
2025-06-30Post Ipo Debt· $100M
Leadership Team
John Cox
Chief Executive Officer
Recent News
2026-01-11
2026-01-07
Company data provided by crunchbase